HealthEquity Valuation

HQY Stock  USD 79.72  0.24  0.30%   
At this time, the firm appears to be undervalued. HealthEquity retains a regular Real Value of $88.1 per share. The prevalent price of the firm is $79.72. Our model calculates the value of HealthEquity from evaluating the firm fundamentals such as return on asset of 0.0256, and Return On Equity of 0.0284 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Price Book
3.365
Enterprise Value
7.4 B
Enterprise Value Ebitda
26.0146
Price Sales
6.8421
Forward PE
42.1941
Undervalued
Today
79.72
Please note that HealthEquity's price fluctuation is very steady at this time. Calculation of the real value of HealthEquity is based on 3 months time horizon. Increasing HealthEquity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for HealthEquity is useful when determining the fair value of the HealthEquity stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of HealthEquity. Since HealthEquity is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HealthEquity Stock. However, HealthEquity's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  79.72 Real  88.1 Target  85.9 Hype  79.72 Naive  79.4
The real value of HealthEquity Stock, also known as its intrinsic value, is the underlying worth of HealthEquity Company, which is reflected in its stock price. It is based on HealthEquity's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of HealthEquity's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence HealthEquity's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
88.10
Real Value
89.66
Upside
Estimating the potential upside or downside of HealthEquity helps investors to forecast how HealthEquity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HealthEquity more accurately as focusing exclusively on HealthEquity's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.630.660.74
Details
Hype
Prediction
LowEstimatedHigh
78.1679.7281.28
Details
Naive
Forecast
LowNext ValueHigh
77.8579.4080.96
Details
13 Analysts
Consensus
LowTarget PriceHigh
78.1785.9095.35
Details

HealthEquity Investments

(48.38 Million)

HealthEquity Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining HealthEquity's current stock value. Our valuation model uses many indicators to compare HealthEquity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HealthEquity competition to find correlations between indicators driving HealthEquity's intrinsic value. More Info.
HealthEquity is rated # 2 in price to sales category among related companies. It is one of the top stocks in price to earning category among related companies reporting about  76.77  of Price To Earning per Price To Sales. . Comparative valuation analysis is a catch-all model that can be used if you cannot value HealthEquity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HealthEquity's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HealthEquity's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HealthEquity's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HealthEquity and how it compares across the competition.

About HealthEquity Valuation

The stock valuation mechanism determines the current worth of HealthEquity on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of HealthEquity. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of HealthEquity based exclusively on its fundamental and basic technical indicators. By analyzing HealthEquity's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of HealthEquity's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of HealthEquity. We calculate exposure to HealthEquity's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to HealthEquity's related companies.
Last ReportedProjected for 2024
Gross Profit529.9 M556.4 M
Pretax Profit Margin 0.08  0.12 
Operating Profit Margin 0.13  0.18 
Net Profit Margin 0.06  0.11 
Gross Profit Margin 0.53  0.46 

8 Steps to conduct HealthEquity's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HealthEquity's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HealthEquity's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain HealthEquity's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine HealthEquity's revenue streams: Identify HealthEquity's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research HealthEquity's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish HealthEquity's growth potential: Evaluate HealthEquity's management, business model, and growth potential.
  • Determine HealthEquity's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HealthEquity's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

HealthEquity Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as HealthEquity does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding87 M
Quarterly Earnings Growth Y O Y-0.96
Forward Price Earnings42.1941

HealthEquity Current Valuation Indicators

Valuation refers to the process of determining the present value of HealthEquity and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value HealthEquity we look at many different elements of the entity such as HealthEquity's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. HealthEquity's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final HealthEquity's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as HealthEquity, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use HealthEquity's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes HealthEquity's worth.
When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
0.64
Revenue Per Share
11.682
Quarterly Revenue Growth
0.122
Return On Assets
0.0256
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.